Skip to main content

Table 3 Number of cases that expressed (“positive cases”, 1+ to 3+) and those with “high expression” (> 25%, 2+ or 3+) for each VEGF subunit and cognate receptora

From: The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas

  Positive cases N High expression N
VEGF-A 57/62 (91.9%) 49/57 (85.9%)
VEGF-C 53/56 (94.6%) 48/53 (90.5%)
VEGF-D 55/63 (87.3%) 49/55 (89.0%)
VEGF-R1 65/66 (98.5%) 55/65 (84.6%)
VEGF-R2 63/64 (98.4%) 56/63 (88.8%)
VEGF-R3 49/50 (98.0%) 46/49 (93.8%)
  1. a > 25% of immunostaining in the core area